Green Cures & Botanical Distribution Inc. announces the immediate availability of its new and improved Tincture by Green Cures through Amazon.com and Allcbd.com
Green Cures & Botanical Distribution Inc. (OTC Pink: GRCU) (“Green Cures”), a cannabis and industrial hemp products innovator, announced today the immediate availability of its new and improved CBD Tincture by Green Cures, which contains 200 mg of rich hemp CBD oil.
Management of Green Cures is excited to announce that the new and improved Tincture by Green Cures is immediately available for purchase through www.amazon.com and www.allcbd.com. CBD Tinctures by Green Cures (200 mg) is currently being offered in a natural flavor. The company stated that additional flavors for the new tinctures will be added to www.amazon.com andwww.allcbd.com in the near future. Management of Green Cures also informed to the public and the investment community that a potency report for the latest Tincture has been uploaded to www.allcbd.com.
As stated in previous releases, numerous properties and benefits of CBD are being investigated at academic research centers in the United States and elsewhere. The FDA has not evaluated the validity or truthfulness of these claims. As such, Green Cures management encourages its customers and the market in general to review the published research relating to the benefits and properties of CBD hemp oils and other CBD infused products, and to educate themselves on the potential use and benefits of these oils and products. Green Cures management will continue to monitor research results relating to the benefits and properties of CBD hemp oils and other products as well.
Additional Update:
In connection with the previous announcement dated March 5, 2015, the company wishes to clarify that Green Cures does not market or sell any type of products that are not within the guidelines of the federal law. Green Cures stated that if at a later time, the company becomes able to market or sell products derived from processed hemp seed, or fiber produced in the U.S. Green Cures or its suppliers will only purchase U.S. hemp materials from entities or farmers that are in compliance with federal and state laws, and in compliance with section 7606 of The Farm Bill 2014.
The company will provide additional updates as they become available.
FDA Statement: The statements contained in this document have not been evaluated or approved by the FDA. The products and statements referenced in this document are not intended to diagnose, treat, cure, or prevent any disease.
Forward-looking statement: This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Forward-looking statements are identified by wording such as “scheduled (future sense)”, “intend(s)”, “plan(s)”, “expect(s)”, “believe(s)”, “will”, “estimate(s)”, “anticipate(s)”, “expect(s)”, “may”, “would”, “could” or “should” or, in each case, the negative thereof, other variations thereon, or comparable terminology that implies anticipated future deliverables. The Company disclaims any obligation or intention to update any forward-looking statement for any reason.
To view the original version on PR Newswire, visit:https://www.prnewswire.com/news-releases/green-cures–botanical-distribution-inc-announces-the-immediate-availability-of-its-new-and-improved-tincture-by-green-cures-through-amazoncom-and-allcbdcom-300051947.html
MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
